The proposed combination involves corporate restructuring of JVCO, including through acquisition by Haleon via demerger
Operations at Oakville, Canada manufacturing plant expected to end by first quarter 2023
The acquisition will strengthen Lupin’s India formulation business by adding a fast-growing portfolio of vitamins, minerals, supplements and neurological products
Veritaz has over 40 brands marketed across the acute and critical care therapeutic segments
Casimir further differentiates Emmes’ industry-leading rare disease research capabilities
Brazil has the 4th largest pet market in the world with an estimated market size of BRL 1.8 billion, growing annually at 16%
Mankind Pharma has agreed to retain Panacea Biotec’s sales and marketing team engaged in this business
Adds to Merck’s growing global, multi-modality CDMO network, following newly formed CDMO business unit in Life Science
CliniSys has the proven ability to deliver 100s of millions of medical results a month to enable pandemic-scale population disease surveillance across the globe
The combination enhances Comar's customer value proposition by adding complementary closure and jar products and related precision mold-making expertise
Subscribe To Our Newsletter & Stay Updated
